This was the stock's fourth consecutive day of losses.
Henry Schein, Inc. (Nasdaq: HSIC) announced today that Stanley M. Bergman, Chairman of the Board and Chief Executive Officer, ...
BofA analyst Allen Lutz double upgraded Henry Schein (HSIC) to Buy from Underperform with a price target of $84, up from $69. The firm believes ...
Tokio Marine Asset Management Co. Ltd. grew its position in shares of Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 13.1% ...
Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Henry Schein HSIC in the last three months. The table below offers a condensed view of their ...
Analysts at Barrington Research cut their Q1 2025 earnings estimates for shares of Henry Schein in a research report issued ...
Henry Schein, Inc. (NASDAQ:HSIC) shares are trading higher on Wednesday. The medical and dental supplies distributor disclosed a strategic investment of an additional $250 million from funds ...
Stripping out certain one-off items, Henry Schein expects to report adjusted earnings of $1.19 a share. The company estimated fourth-quarter revenue would rise slightly to $3.2 billion.
Henry Schein (HSIC) announced a strategic investment by funds affiliated with KKR,(KKR) a global investment firm.In addition to KKR’s current ...
As a result, KKR will become the largest non-index fund shareholder in the Company with a 12% position, demonstrating the firm’s confidence in Henry Schein, its management team, and its BOLD+1 ...